Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
about
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenPediatric AML: From Biology to Clinical ManagementThe ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsHematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path?Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries.Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998-2012.Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial.Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort AnalysisHematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation.A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre.Help-seeking behaviour of patients with haematological malignancies treated with autologous stem cell transplantation.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016.Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection.First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation groAutologous stem cell transplant for multiple myeloma patients 70 years or older.Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents.Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study.Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML.Hematopoietic progenitor cells collection in pediatric patients with brain tumor.
P2860
Q26798470-FB0CE98B-C591-4B67-BA23-831E70A95C8AQ26799773-5291E4BD-71DB-45FE-B012-762C88D4116BQ27002660-03A3E52E-C184-4F94-B105-36840B562C2EQ28072887-D0F28795-DB62-41BE-A968-BA64AA46F4CDQ30315865-25265CD8-B9A2-4E55-BD17-A7822A958C3BQ31022472-F3ED739B-C2DA-40CA-9500-4C12EEA4DAEBQ33786536-1586E312-02C0-49A9-9D77-F18A5C27F885Q34463419-183CCC2C-070D-47E6-8F10-A967E3BD7C5DQ34625543-DF51A795-E7C0-462C-AAD5-E2613056E46CQ35085078-4B099E46-797C-4959-B867-194289C1CA20Q35288778-C07BEAB4-645F-44BE-90CD-700F872945D5Q35658742-6399AA57-6CB0-4E90-90DD-7D2F20617B6BQ36566280-22A47920-EABA-4784-A7AE-522887024A8CQ36928803-9337C253-2E89-437C-972F-2399284830BFQ36974379-6A7A43BF-AECD-44FD-AD74-6073C3EE47C9Q38260255-44BCFC6F-E0B3-4744-A18F-F17CF0F85807Q38323097-F12961E4-514E-4BB9-934E-8A8F5373CC71Q38540862-902D0F92-5CF4-4E0B-B812-2527E06CEA19Q38652761-ABAEE4D1-F3BD-4429-A19E-822805AF61C0Q38690071-3543387F-5BC7-45AB-990E-1F175382CA53Q38751585-A9C06902-4642-4027-A162-A494AAEE8398Q38797541-2127F76C-0953-47BA-8183-976FC1B5849CQ38827118-2B0A8436-08CF-4DA9-A5B8-7A9FF09AE685Q38912633-5B2401C9-5425-46C6-8B38-C4C54A4BB1B4Q38922475-6197949E-4F3F-4A51-A03C-862B16B3753AQ39004671-52C028F6-5165-47E2-9C01-0450F5354E34Q39052615-08665BA5-562E-486D-B799-6EA618AF6480Q39400593-F0BFE0C6-76C0-4A63-8B81-BB54B653DDBCQ39633772-7C6218D5-CBF5-40FF-AABC-C25A1CCA3C05Q39822035-779388F3-5FCE-460D-BAFC-B1B1D8297281Q40370932-BA516EF8-9C90-47DF-B6B6-235B1B5F1CBFQ40490106-A6804007-9FD3-4FEB-A77B-D78FDEF88EA0Q40766348-AB59E5A9-DC34-4444-BD59-03672690899EQ40896003-8602A7CB-C963-4D03-8671-EECE20AC894AQ41070207-09962A90-E1C5-46E1-9DE7-AF5853CF0932Q42181212-338D6FD6-3B1C-46FB-BE71-20F038E8E8B3Q47263508-001BE38D-624A-47E5-8E1F-8528BF835DE9Q48058540-BD0A377F-F290-45B7-B07E-5348EA8F9D2EQ48142819-C2016F74-FB7A-4A21-B53A-B6E53BDB51F9Q48241658-90CE4D83-C02E-4B1A-B318-9F815C0E3920
P2860
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@ast
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@en
type
label
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@ast
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@en
prefLabel
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@ast
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@en
P2093
P2860
P50
P356
P1476
Hematopoietic SCT in Europe: d ...... n of pediatric transplantation
@en
P2093
D Farge-Bancel
European Society for Blood and Marrow Transplantation EBMT
H B Gaspar
H Baldomero
J H F Falkenburg
P2860
P2888
P304
P356
10.1038/BMT.2014.55
P407
P577
2014-03-17T00:00:00Z
P5875
P6179
1032899887